Section 109051.
Cal. Health and Safety Code - HSC § 109051.
in effectFor purposes of this chapter, the following terms have the following definitions:
(a)
“DEHP” means Di(2-ethylhexyl) phthalate.
(b)
“Intentionally added DEHP” means DEHP that a manufacturer has intentionally added to an intravenous solution container or intravenous tubing product that has a functional or technical effect on the product.
(c)
“Intravenous solution containers” means a container used to house medicine, fluid, or nutrition therapy that is intravenously administered to patients in a hospital, outpatient, or other health care facility.
(d)
“Intravenous tubing” means any tubing used to intravenously administer fluids, medication, or nutrients directly to an adult, child, or infant.
(e)
“Ortho-phthalates” means a class of chemicals that are esters of ortho-phthalic acid, including all of the following:
(1)
Benzyl-butyl phthalate (BBP) 85-68-7.
(2)
Dibutyl phthalate (DBP) 84-74-2.
(3)
Dicyclohexyl phthalate (DCHP) 84-61-7.
(4)
Di-(2-ethylhexyl) phthalate (DEHP) 117-81-7.
(5)
Diethyl phthalate (DEP) 84-66-2.
(6)
Di-isobutyl phthalate (DIBP) 84-69-5.
(7)
Di-isodecyl phthalate (DIDP) 26761-40-0.
(8)
Di-isononyl phthalate (DINP) 28553-12-0.
(9)
Di-n-hexyl phthalate (DnHP) 84-75-3.
(10)
Di-n-octyl phthalate (DNOP) 117-84-0.
(11)
Di-n-pentyl (DnPP) phthalate 131-18-0.
(12)
Diisoheptyl phthalate (DIHP) 71888-89-6.
(f)
“Unintentionally added DEHP” means DEHP in an intravenous solution container or intravenous tubing product that is
not used for functional or technical effect on the product.
Source: CA Legislative Counsel Bulk DataURL: https://downloads.leginfo.legislature.ca.gov/pubinfo_2025.zipFetched: 6/27/2026